Last update 01 Nov 2024

DNA-directed DNA polymerase x RT x Tubulin

Basic Info

Related Targets
DNA-directed DNA polymeraseRTTubulin

Related

1
Drugs associated with DNA-directed DNA polymerase x RT x Tubulin
Carbendazim
Target
DNA-directed DNA polymerase x RT x Tubulin
Mechanism
DNA-directed DNA polymerase inhibitors [+2]
Active Org.-
Originator Org.
Procter & Gamble Co.Procter & Gamble Co.
Active Indication-
Inactive Indication
HIV Infections [+1]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
2
Clinical Trials associated with DNA-directed DNA polymerase x RT x Tubulin
NCT00023816 / Unknown statusPhase 1IIT
Third Phase I and Pharmacokinetic Study Of FB-642 Administered Orally To Patients With Advanced Solid Tumors
NCT00003709 / CompletedPhase 1IIT
Phase I and Pharmacokinetic Study of FB-642 Administered Orally on a Weekly Schedule to Patients With Advanced Solid Tumors
100 Clinical Results associated with DNA-directed DNA polymerase x RT x Tubulin
Login to view more data
100 Translational Medicine associated with DNA-directed DNA polymerase x RT x Tubulin
Login to view more data
0 Patents (Medical) associated with DNA-directed DNA polymerase x RT x Tubulin
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free